Literature DB >> 20359241

Baiting proteins with C60.

Matteo Calvaresi1, Francesco Zerbetto.   

Abstract

About 20 proteins are known to modify their activity upon interaction with C60. Their structures are present in a database that includes more than 1200 protein structures selected as possible targets for drugs and to represent the entire Protein Data Bank. The set was examined with an algorithm that appraises quantitatively the interaction of C60 and the surface of each protein. The redundancy of the set allows to establish the predictive power of the approach that finds explicitly the most probable site where C60 docks on each protein. About 80% of the known fullerene binding proteins fall in the top 10% of scorers. The close match between the model and experiments vouches for the accuracy of the model and validates its predictions. The sites of docking are shown and discussed in view of the existing experimental data available for protein-C60 interaction. A closer exam of the 10 top scorers is discussed in detail. New proteins that can interact with C60 are identified and discussed for possible future applications as drug targets and fullerene derivatives bioconjugate materials.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20359241     DOI: 10.1021/nn901809b

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  22 in total

1.  Deformation density components analysis of fullerene-based anti-HIV drugs.

Authors:  Sara Fakhraee; Maryam Souri
Journal:  J Mol Model       Date:  2014-11-13       Impact factor: 1.810

2.  The influence of the configuration of the (C70)2 dimer on its rovibrational spectroscopic properties: a theoretical survey.

Authors:  Rodrigo A L Silva; Sandro F de Brito; Daniel F S Machado; Valter H Carvalho-Silva; Heibbe C B de Oliveira; Luciano Ribeiro
Journal:  J Mol Model       Date:  2018-08-15       Impact factor: 1.810

Review 3.  Mechanisms of carbon nanotube-induced toxicity: focus on oxidative stress.

Authors:  Anna A Shvedova; Antonio Pietroiusti; Bengt Fadeel; Valerian E Kagan
Journal:  Toxicol Appl Pharmacol       Date:  2012-04-06       Impact factor: 4.219

4.  Towards water-soluble [60]fullerenes for the delivery of siRNA in a prostate cancer model.

Authors:  Julia Korzuch; Monika Rak; Katarzyna Balin; Maciej Zubko; Olga Głowacka; Mateusz Dulski; Robert Musioł; Zbigniew Madeja; Maciej Serda
Journal:  Sci Rep       Date:  2021-05-19       Impact factor: 4.996

5.  A large-scale association study for nanoparticle C60 uncovers mechanisms of nanotoxicity disrupting the native conformations of DNA/RNA.

Authors:  Xue Xu; Xia Wang; Yan Li; Yonghua Wang; Ling Yang
Journal:  Nucleic Acids Res       Date:  2012-06-01       Impact factor: 16.971

6.  Preferential binding of fullerene and fullerenol with the N-terminal and middle regions of amyloid beta peptide: an in silico investigation.

Authors:  Vishal Pandya; Lokesh Baweja; Alok Dhawan
Journal:  Int J Nanomedicine       Date:  2018-03-15

7.  Effect of buckminsterfullerenes on cells of the innate and adaptive immune system: an in vitro study with human peripheral blood mononuclear cells.

Authors:  Hanno Bunz; Sandra Plankenhorn; Reinhild Klein
Journal:  Int J Nanomedicine       Date:  2012-08-20

Review 8.  Nanoinformatics: emerging databases and available tools.

Authors:  Suresh Panneerselvam; Sangdun Choi
Journal:  Int J Mol Sci       Date:  2014-04-25       Impact factor: 5.923

9.  Protein-directed self-assembly of a fullerene crystal.

Authors:  Kook-Han Kim; Dong-Kyun Ko; Yong-Tae Kim; Nam Hyeong Kim; Jaydeep Paul; Shao-Qing Zhang; Christopher B Murray; Rudresh Acharya; William F DeGrado; Yong Ho Kim; Gevorg Grigoryan
Journal:  Nat Commun       Date:  2016-04-26       Impact factor: 14.919

10.  Analyses of the Binding between Water Soluble C60 Derivatives and Potential Drug Targets through a Molecular Docking Approach.

Authors:  Muhammad Junaid; Eman Abdullah Almuqri; Junjun Liu; Houjin Zhang
Journal:  PLoS One       Date:  2016-02-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.